Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hormonal, Metabolic, and Signaling Interaction in Pulmonary Arterial Hypertension

NCT01884051 is registered in ClinicalTrials.gov with Vanderbilt University Medical Center as lead sponsor.

NCT NCT01884051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01884051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hormonal, Metabolic, and Signaling Interaction in Pulmonary Arterial Hypertension
Lead sponsor
Vanderbilt University Medical Center
Phase
Observational
Overall status
Recruiting
Start date
September 30, 2012
Completion date
July 31, 2032
Enrollment
1,899 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

appetite suppressant associate pah, heritable pulmonary arterial hypertension, idiopathic pulmonary arterial hypertension, scleroderma associated pulmonary arterial hypertension